From Handwiki
Pharmacology: major drug groups | |
|---|---|
| Gastrointestinal tract/ metabolism (A) |
|
| Blood and blood forming organs (B) |
|
| Cardiovascular system (C) |
|
| Skin (D) |
|
| Genitourinary system (G) |
|
| Endocrine system (H) |
|
| Infections and infestations (J, P, QI) |
|
| Malignant disease (L01–L02) |
|
| Immune disease (L03–L04) |
|
| Muscles, bones, and joints (M) |
|
| Brain and nervous system (N) |
|
| Respiratory system (R) |
|
| Sensory organs (S) |
|
| Other ATC (V) |
|
Cardiac glycosides (C01A) | |||||||
|---|---|---|---|---|---|---|---|
| Bufadienolides |
| ||||||
| Cardenolides |
| ||||||
| |||||||
Antiarrhythmic agents (C01B) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Channel blockers |
| ||||||||||||
| Receptor agonists<BR>and antagonists |
| ||||||||||||
| Ion transporters |
| ||||||||||||
| |||||||||||||
Cardiac stimulants excluding cardiac glycosides (C01C) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adrenergic and dopaminergic agents |
| ||||||||||||||
| Phosphodiesterase inhibitors (PDE3I) |
| ||||||||||||||
| Other cardiac stimulants |
| ||||||||||||||
| |||||||||||||||
Vasodilators used in cardiac diseases (C01D) | |
|---|---|
| Nitrovasodilators |
|
| Quinolone vasodilators |
|
| Others |
|
| |
Sympatholytic (and closely related) antihypertensives (C02) | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sympatholytics (antagonize α-adrenergic vasoconstriction) |
| ||||||||||||||||||||||||||
| Other antagonists |
| ||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
Nonsympatholytic vasodilatory antihypertensives (C02) | |||||
|---|---|---|---|---|---|
| Nitrovasodilator |
| ||||
| (arteriolar) Potassium channel opener |
| ||||
| (arteriolar) Calcium channel blocker |
| ||||
| |||||
Antihypertensives: diuretics (C03) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sulfonamides (and etacrynic acid) |
| ||||||||
| Potassium-sparing (at CD) |
| ||||||||
| Osmotic diuretics (PT, DL) |
| ||||||||
| Vasopressin receptor inhibitors (DCT and CD) |
| ||||||||
| Other |
| ||||||||
| |||||||||
Peripheral vasodilators (C04) | |
|---|---|
| Phenylethanolamine derivatives |
|
| Alpha blockers |
|
| Niacin and derivatives |
|
| Purine derivatives |
|
| Ergot alkaloids |
|
| Other peripheral vasodilators |
|
Vasoprotectives (C05) | |||||||
|---|---|---|---|---|---|---|---|
| Antihemorrhoidals for topical use |
| ||||||
| Antivaricose therapy |
| ||||||
| Capillary stabilising agents |
| ||||||
Beta blockers (C07) | |
|---|---|
| β, non-selective |
|
| β1-selective |
|
| β2-selective |
|
| α1- + β-selective |
|
| |
Ion channel modulators | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calcium |
| ||||||||||||||||||||||||
| Potassium |
| ||||||||||||||||||||||||
| Sodium |
| ||||||||||||||||||||||||
| Chloride |
| ||||||||||||||||||||||||
| Others |
| ||||||||||||||||||||||||
See also: Receptor/signaling modulators • Transient receptor potential channel modulators | |||||||||||||||||||||||||
Antihypertensives: agents acting on the renin–angiotensin system (C09) | |
|---|---|
| ACE inhibitors ("-pril") |
|
| AIIRAs ("-sartan") |
|
| Renin inhibitors ("-kiren") |
|
| Dual ACE/NEP inhibitors |
|
| Neprilysin inhibitors |
|
| |
Lipid-modifying agents (C10) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| GI tract |
| ||||||||
| Liver |
| ||||||||
| Blood vessels |
| ||||||||
| Combinations |
| ||||||||
| Other |
| ||||||||
| |||||||||
![]() | 0.00 ![]() ![]() ![]() ![]() (0 votes) |
Categories: [ATC codes]
KSF
